Exploration of tumor suppressors p16(INK4a) and p14(ARF) in oral leukoplakias

被引:0
|
作者
Nitsche, Matthias [1 ]
Koy, Susanne [1 ]
Moerz, Michael [2 ]
Koch, Rainer [3 ]
Eckelt, Uwe [1 ]
机构
[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin MKG Chirurg, Fetscherstr 74, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Abt Chirurg Forsch, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Inst Med Informat & Biometrie, Med Fak, D-01307 Dresden, Germany
来源
关键词
p16; p14(ARF); Leukoplakia; Oral mucosa;
D O I
10.1007/s10006-007-0086
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The inactivation of p16 and p14(ARF) is considered to be an important step in the carcinogenesis of oropharygeal carcinomas. This consideration is supported by the observation of multiple allelic losses in the coding loci of chromosome 9p21 in squamous cell carcinomas and in dysplastic premalignant lesions. The present study hypothesized that comparable alterations already occur in leukoplakia, which are seen as potential predecessors of oral squamous cell carcinomas and that it is possible to differ leukoplakia with from leukoplakia without further malignant transformation. Furthermore we evaluated, whether such leukoplakia show sequence alterations in the genes p16 and p14(ARF), which are capable to cause a limitation in gene function. The results show that the LOH pattern in genes p16 and p14(ARF) occur as well in leuplakia with malignant transformation as in leukoplakia, that do not show clinical alterations. The rate of allelic loss did not differ significantly. Overall, the incidence of allelic loss was lower in leuplakia compared to succeeding squamous-cell carcinomas (p < 0,05). The results further illustrated an increase in LOH patterns in dyplastic leukoplakia, without reaching statistical significance. Significant increases in allelic losses were found in heavy smokers, (p < 0,05). PCR analysis of the exons 1-alpha, exon 1-beta and exon 2 in leukoplakia, containing LOH patterns did not show genetic alterations. Thus we concluded, that gene deletion and gene mutation have a minor role in the inactivation process of p16 and p14ARF in oral leukoplakia. Representing an early process in carcinogenesis, gene deletion and mutation occur in leukoplakia with and without malignant transformation. Therefore, taken as a singular parameter they represent an uncertain criteria to assess the potential of malignant transformation. However they could provide information in combination with other genetic factors like chromosomal methylation patterns and histology.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 50 条
  • [1] Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias [Untersuchung der Tumorsuppressoren p16INK4a und p14ARF in Mundschleimhautleukoplakien]
    Nitsche M.
    Koy S.
    Mörz M.
    Koch R.
    Eckelt U.
    [J]. Mund-, Kiefer- und Gesichtschirurgie, 2007, 11 (6): : 317 - 326
  • [2] Survey of familial glioma and role of germline p16 INK4A/p14 ARF and p53 mutation
    Robertson, Lindsay B.
    Armstrong, Georgina N.
    Olver, Bianca D.
    Lloyd, Amy L.
    Shete, Sanjay
    Lau, Ching
    Claus, Elizabeth B.
    Barnholtz-Sloan, Jill
    Lai, Rose
    Il'yasova, Dora
    Schildkraut, Joellen
    Bernstein, Jonine L.
    Olson, Sara H.
    Jenkins, Robert B.
    Yang, Ping
    Rynerason, Amanda L.
    Wrensch, Margaret
    McCoy, Lucie
    Wienkce, John K.
    McCarthy, Bridget
    Davis, Faith
    Vick, Nicholas A.
    Johansen, Christoffer
    Bodtcher, Hanne
    Sadetzki, Siegal
    Bruchim, Revital Bar-Sade
    Yechezkel, Galit Hirsh
    Andersson, Ulrika
    Melin, Beatrice S.
    Bondy, Melissa L.
    Houlston, Richard S.
    [J]. FAMILIAL CANCER, 2010, 9 (03) : 413 - 421
  • [3] Alterations of p14 ARF, p15 INK4b , and p16 INK4a Genes in Primary Laryngeal Squamous Cell Carcinoma
    Lopez, Fernando
    Sampedro, Teresa
    Llorente, Jose L.
    Hermsen, Mario
    Alvarez-Marcos, Cesar
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (01) : 63 - 71
  • [4] Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus
    Kabir, Farruk M. Lutful
    Agarwal, Payal
    DeInnocentes, Patricia
    Zaman, Jishan
    Bird, Allison Church
    Bird, R. Curtis
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (01) : 56 - 66
  • [5] Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case–control study in North Indian population
    Marjan Askari
    Ranbir Chander Sobti
    Mohsen Nikbakht
    Suresh C. Sharma
    [J]. Molecular Biology Reports, 2013, 40 : 4921 - 4928
  • [6] p16(INK4A) as a human tumor suppressor
    Shapiro, GI
    Rollins, BJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1242 (03): : 165 - 169
  • [7] Alteration of the p53 and Rb tumor suppressor pathways by p16/INK4a and p14/ARF promoter methylation and loss of protein expression in recurrent and nonrecurrent meningiomas
    Carlos Martinez, Juan
    Ropero, Santiago
    Mateos, Concepcion
    Del Val Toledo, Maria
    Samaniego, Rafael
    Sacristan, Silvia
    Esteller, Manel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case-control study in North Indian population
    Askari, Marjan
    Sobti, Ranbir Chander
    Nikbakht, Mohsen
    Sharma, Suresh C.
    [J]. MOLECULAR BIOLOGY REPORTS, 2013, 40 (08) : 4921 - 4928
  • [9] Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma
    Hutter, G
    Scheubner, M
    Zimmermann, Y
    Kalla, J
    Katzenberger, T
    Hübler, K
    Roth, S
    Hiddemann, W
    Ott, G
    Dreyling, M
    [J]. GENES CHROMOSOMES & CANCER, 2006, 45 (02): : 203 - 210
  • [10] Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14 ARF and p16 INK4a) gene in Esophageal squamous cell carcinoma
    Ito, Shuhei
    Ohga, Takefumi
    Saeki, Hiroshi
    Watanabe, Masayuki
    Kakeji, Yoshihiro
    Morita, Masaru
    Yamada, Tomomi
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2007, 27 (5A) : 3345 - 3353